BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29523144)

  • 1. The use and preference of artemether as a first-choice treatment for malaria: results from a cross-sectional survey in the Bata district, Equatorial Guinea.
    Romay-Barja M; Ncogo P; Nseng G; Santana-Morales MA; Berzosa P; Herrador Z; Valladares B; Riloha M; Benito A
    Malar J; 2018 Mar; 17(1):107. PubMed ID: 29523144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of delay in malaria care-seeking behaviour for children 15 years and under in Bata district, Equatorial Guinea.
    Romay-Barja M; Cano J; Ncogo P; Nseng G; Santana-Morales MA; Valladares B; Riloha M; Benito A
    Malar J; 2016 Mar; 15():187. PubMed ID: 27036554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failures in the case management of children with uncomplicated malaria in Bata district of Equatorial Guinea and associated factors.
    Suárez-Sánchez P; García B; Nzang J; Ncogo P; Riloha M; Berzosa P; Benito A; Romay-Barja M
    PLoS One; 2019; 14(8):e0220789. PubMed ID: 31374107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rural-Urban Differences in Household Treatment-Seeking Behaviour for Suspected Malaria in Children at Bata District, Equatorial Guinea.
    Romay-Barja M; Jarrin I; Ncogo P; Nseng G; Sagrado MJ; Santana-Morales MA; Aparicio P; Valladares B; Riloha M; Benito A
    PLoS One; 2015; 10(8):e0135887. PubMed ID: 26284683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caregivers' Malaria Knowledge, Beliefs and Attitudes, and Related Factors in the Bata District, Equatorial Guinea.
    Romay-Barja M; Ncogo P; Nseng G; Santana-Morales MA; Herrador Z; Berzosa P; Valladares B; Riloha M; Benito A
    PLoS One; 2016; 11(12):e0168668. PubMed ID: 28036341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria prevalence in Bata district, Equatorial Guinea: a cross-sectional study.
    Ncogo P; Herrador Z; Romay-Barja M; García-Carrasco E; Nseng G; Berzosa P; Santana-Morales MA; Riloha M; Aparicio P; Valladares B; Benito A
    Malar J; 2015 Nov; 14():456. PubMed ID: 26573911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
    Dorsey G; Staedke S; Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Dokomajilar C; Kamya MR; Rosenthal PJ
    JAMA; 2007 May; 297(20):2210-9. PubMed ID: 17519410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study.
    Gebrekidan MG; Gebremedhin GB; Gebregiorgis YS; Gezehegn AA; Weldearegay KT
    Antimicrob Resist Infect Control; 2020 Nov; 9(1):184. PubMed ID: 33168093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study.
    Nyeko R; Otim F; Obiya EM; Abala C
    Malar J; 2023 Mar; 22(1):103. PubMed ID: 36941616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial clustering and risk factors of malaria infections in Bata district, Equatorial Guinea.
    Gómez-Barroso D; García-Carrasco E; Herrador Z; Ncogo P; Romay-Barja M; Ondo Mangue ME; Nseng G; Riloha M; Santana MA; Valladares B; Aparicio P; Benito A
    Malar J; 2017 Apr; 16(1):146. PubMed ID: 28403879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.
    Toure OA; Assi SB; N'Guessan TL; Adji GE; Ako AB; Brou MJ; Ehouman MF; Gnamien LA; Coulibaly MA; Coulibaly B; Beourou S; Bassinka I; Soumahoro A; Kadjo F; Tano MA
    Malar J; 2014 Nov; 13():439. PubMed ID: 25409546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with appropriate home management of uncomplicated malaria in children in Kassena-Nankana district of Ghana and implications for community case management of childhood illness: a cross-sectional study.
    Ameh S; Welaga P; Kabiru CW; Ndifon W; Ikpeme B; Nsan E; Oyo-Ita A
    BMC Public Health; 2015 May; 15():458. PubMed ID: 25934315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.
    Sondo P; Derra K; Diallo-Nakanabo S; Tarnagda Z; Zampa O; Kazienga A; Valea I; Sorgho H; Owusu-Dabo E; Ouedraogo JB; Guiguemde TR; Tinto H
    Malar J; 2015 Aug; 14():325. PubMed ID: 26289949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, trends and associated factors of malaria in the Shai-Osudoku District Hospital, Ghana.
    Tetteh JA; Djissem PE; Manyeh AK
    Malar J; 2023 Apr; 22(1):131. PubMed ID: 37087510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and practices regarding malaria and the National Treatment Guidelines among public health workers in Equatorial Guinea.
    Blanco M; Suárez-Sanchez P; García B; Nzang J; Ncogo P; Riloha M; Berzosa P; Benito A; Romay-Barja M
    Malar J; 2021 Jan; 20(1):21. PubMed ID: 33413402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy.
    Asante KP; Abokyi L; Zandoh C; Owusu R; Awini E; Sulemana A; Amenga-Etego S; Adda R; Boahen O; Segbaya S; Mahama E; Bart-Plange C; Chandramohan D; Owusu-Agyei S
    BMC Public Health; 2010 Jul; 10():409. PubMed ID: 20624306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.